Advertisement
Singapore markets closed
  • Straits Times Index

    3,216.91
    -10.70 (-0.33%)
     
  • Nikkei

    39,523.55
    +80.92 (+0.21%)
     
  • Hang Seng

    16,721.69
    -373.34 (-2.18%)
     
  • FTSE 100

    7,995.58
    +71.78 (+0.91%)
     
  • Bitcoin USD

    66,816.95
    -3,441.34 (-4.90%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,115.03
    -84.03 (-1.62%)
     
  • Dow

    37,925.15
    -533.93 (-1.39%)
     
  • Nasdaq

    16,147.16
    -295.04 (-1.79%)
     
  • Gold

    2,353.40
    -19.30 (-0.81%)
     
  • Crude Oil

    85.40
    +0.38 (+0.45%)
     
  • 10-Yr Bond

    4.4990
    -0.0770 (-1.68%)
     
  • FTSE Bursa Malaysia

    1,551.04
    -2.47 (-0.16%)
     
  • Jakarta Composite Index

    7,286.88
    +32.48 (+0.45%)
     
  • PSE Index

    6,659.39
    -18.26 (-0.27%)
     

Is Gilead Sciences a Good Stock to Buy Now?

Is Gilead Sciences a Good Stock to Buy Now?

Shares of Gilead Sciences (NASDAQ: GILD) marched higher on Thursday, Feb. 2 in response to a fourth-quarter earnings report that exceeded expectations. A day later, the U.S. Food and Drug Administration (FDA) agreed to dramatically increase the addressable patient population for an important cancer drug called Trodelvy. Gilead Sciences splashed out with a $21 billion acquisition of Immunomedics in 2020 for access to Trodelvy.